Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Thermogenesis
company
About
Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $250K
- Industries
- Biotechnology,Health Care,Medical,Medical Device,Therapeutics
- Founded date
- Jan 1, 1986
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Thermogenesis is a health care company that focuses in development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. It is a supplier of enabling technologies for the processing and storage of stem cells and biological tissues. The company was founded by David Demirjian and Philip Coelho.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$250K
Thermogenesis has raised a total of
$250K
in funding over 2 rounds. Their latest funding was raised on
Sep 14, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 14, 2021 | Grant | $250K | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Thermogenesis is funded by 1 investors.
National Institutes of Health (NIH)
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
